Farther Finance Advisors’s Niagen Bioscience NAGE Stock Holding History

Farther Finance Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-20	Closed	-$64	–	6379
2026 Q2	$64	Sell	20 -198	-91%	-$803	﹤0.01%	5838
2026 Q1	$985	Sell	218 -462	-68%	-$2.49K	﹤0.01%	5113
2025 Q4	$4.33K	Buy	680 +665	+4,433%	+$4.63K	﹤0.01%	4388
2025 Q3	$140	Buy	+15	New	+$151	﹤0.01%	4791

Other funds holding NAGE

MGI

Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

ANBT

American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

Farther Finance Advisors's NAGE Position: Q3 2026 in Review

Farther Finance Advisors sold out of Niagen Bioscience (NAGE) in Q3 2026, closing a stake of 20 shares — an estimated $64 sold.

Farther Finance Advisors first reported a position in NAGE in Q3 2025 and held it in 4 quarters. The position peaked at $4.33K in Q4 2025. 4 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.

Farther Finance Advisors reported no remaining Niagen Bioscience position as of Q3 2026 after selling out during the quarter.
Farther Finance Advisors sold 20 Niagen Bioscience shares in Q3 2026, an estimated $64.
Farther Finance Advisors first reported a position in Niagen Bioscience in Q3 2025 and held it in 4 quarters.
Farther Finance Advisors's Niagen Bioscience position peaked at $4.33K in Q4 2025.
4 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.